Harvard Heart Letter

Blood clots a late hazard for drug-coated stents

A very small percentage of those who receive a drug-coated stent experience a clot. The most likely cause is discontinuing the clot-preventing combination of aspirin and Plavix too soon after surgery.

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In